Abstract
The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.
Original language | English |
---|---|
Pages (from-to) | 19-24 |
Number of pages | 6 |
Journal | Journal of Neurosurgical Sciences |
Volume | 29 |
Issue number | 1 |
Publication status | Published - 1985 |
ASJC Scopus subject areas
- Clinical Neurology